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In an emerging bioelectronics era, there is a clinical need for physiological devices
incorporating biofeedback that permits natural and demand-dependent control in real
time. Here, we describe a novel device termed a central pattern generator (CPG) that
uses cutting edge analog circuitry producing temporally controlled, electrical stimulus
outputs based on the real time integration of physiological feedback. Motivated by the
fact that respiratory sinus arrhythmia (RSA), which is the cyclical changes in heart rate
every breath, is an essential component of heart rate variability (HRV) (an indicator of
cardiac health), we have explored the versatility and efficiency of the CPG for producing
respiratory modulation of heart rate in anesthetized, spontaneously breathing rats.
Diaphragmatic electromyographic activity was used as the input to the device and its
output connected to either the right cervical vagus nerve or the right atrium for pacing
heart rate. We found that the CPG could induce respiratory related heart rate modulation
that closely mimicked RSA. Whether connected to the vagus nerve or right atrium, the
versatility of the device was demonstrated by permitting: (i) heart rate modulation in any
phase of the respiratory cycle, (ii) control of the magnitude of heart rate modulation, and
(iii) instant adaptation to changes in respiratory frequency. Vagal nerve pacing was only
possible following transection of the nerve limiting its effective use chronically. Pacing
via the right atrium permitted better flexibility and control of heart rate above its intrinsic
level. This investigation now lays the foundation for future studies using this biofeedback
technology permitting closer analysis of both the function and dysfunction of RSA.
Keywords: respiratory sinus arrhythmia, novel biofeedback device, cardiac pacing, vagal nerve stimulation, heart
rate variability
Abbreviations:8, phase shift; dEMG, diaphragmatic electromyogram; E2, period of late expiration; hCPG, hardware central
pattern generator; HR, heart rate; N1, neuron 1; N2, neuron 2; PI, period of post-inspiration; PM-CPG, hCPG format for use
as a cardiac pacemaker; RI, respiratory interval; RMHR, respiratory modulated heart rate; RSA, respiratory sinus arrhythmia;
TI, period of inspiration; V50, voltage for half maximal HR response; VN-CPG, hCPG for vagal nerve stimulation.
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INTRODUCTION
Respiratory sinus arrhythmia (RSA) is the physiological
phenomenon whereby heart accelerates during inspiration and
decelerates during expiration (Anrep et al., 1936). Whilst the
physiological functions of RSA remain ambiguous (Hayano et al.,
1996; Ben-Tal et al., 2012; Elstad et al., 2015), it is clear that the
absence of RSA is a strong prognostic indicator of cardiovascular
pathology (La Rovere et al., 1998). Thus, increasing heart
rate variability (HRV) by reinstating RSA may improve
outcome in patients with cardiovascular diseases such as heart
failure.
Cyclic modulation of heart rate (HR) within each breath
is not possible with existing medical device technology. Such
technology must be a closed-loop system that generates a
physiologically-appropriate stimulus in response to a biological
input, such as respiration, in real time. Therefore, we have
developed a novel analog-hardware central pattern generator
(hCPG) that integrates Hodgkin-Huxley equations in real time to
recapitulate the outputs and dynamics of neurons. The advantage
of hCPG neurons is that their firing sequence is extremely stable
but both highly sensitive and fast to respond (microseconds) to
changes in input signal. By adapting the hCPG neuron phase lags
to changes in rhythm frequency, the hCPG can maintain precise
timing of burst discharges on a breath by breath basis (Nogaret
et al., 2013; Zhao and Nogaret, 2015) that can be used to pace
the heart. Functional circuits have been simulated (Briggman and
Kristan, 2008) but it this the first time their principles are being
implemented in hardware for the application of neurostimulation
in vivo.
We have previously demonstrated the proof-of-principle
hCPG in an in situ rat preparation (Nogaret et al., 2013). This
device was optimized to stimulate the vagus nerve (termed the
VN-CPG) and elicited periodic bradycardia at different times
within the respiratory cycle. The resulting HR waveform is
referred to as respiratory-modulated heart rate (RMHR). The
parameter space and biofeedback capabilities were neither fully
explored nor quantified, which is now a critical step in the
pathway to translation of the device. To fully exploit this device’s
potential for translation we sought to investigate its ability to
generate RMHR as a cardiac pacemaker. Thus, in the present
study, we aimed to: (a) assess the relationship between the
dynamic respiratory input signal of an intact rat and the range
of effective output of the hCPG, (b) explore and quantify the
flexibility of vagal induced respiratory modulation of heart rate,
(c) convert the hCPG into a direct cardiac pacemaker (which
will be referred to as the PM-CPG) and explore its feasibility
and potential for respiratory modulated (i.e., breath by breath)
naturalistic cardiac pacing.
METHODS
Ethical Approval
All animal experiments were performed in accordance with
institutional guidelines and the UK Home Office (Scientific
Procedures) Act (1986) with project approval from the University
of Bristol, University ethics of research committee.
Surgical Preparation
Male Wistar rats (250–350 g, n = 8) were anesthetized
with isofluorane (induction 5%, maintenance 1.5–1.8% in 100%
oxygen). Depth of anesthesia was monitored regularly and
deemed adequate by an absence of pedal withdrawal and
corneal reflex responses. Core temperature was monitored and
maintained (37.1–37.6◦C) by homeothermic blanket (Harvard
Apparatus Ltd, UK). Rats were instrumented to record arterial
pressure, continuous diaphragmatic electromyogram (dEMG)
and HR as follows. Fluid-filled polyethylene catheters were
inserted into the right carotid artery (0.9% saline, 100 IU/mL
heparin) and right jugular vein to record arterial pressure and
maintain hydration (∼3mL/kg/hr of 0.9% saline) respectively. A
pair of nylon-insulated stainless steel wire electrodes (0.25mm
insulated diameter) ending with a suture pad (0.7 × 1.0 ×
3.2mm, Plastics1, USA) were placed 3–4mm apart onto the
costal diaphragm, accessed via medial abdominal incision,
for continuous dEMG (contracts only during inspiration)
recordings. The electrode wires were tunneled out of the
abdomen and connected to the amplifier (AM systems, USA).
Another pair of subcutaneous electrodes to capture the
electrocardiogram R wave were secured bilaterally to the external
intercostal muscles between the second and fourth ribs.
Vagal Nerve Electrode Placement
The right cervical vagus nerve was accessed by midline incision,
separated from the common carotid artery using a glass hook and
placed inside a bipolar cuff electrode, which was closed with a
suture (Polyester braided 6-0, Ethicon, USA). The voltage-based
stimulus output of the VN-CPG was directly connected to the
bipolar cuff electrode leads (Figure 1A). Unilateral vagotomywas
performed by tying two sutures around the nerve cranial to the
cuff electrode and transecting the nerve between the sutures.
Cardiac Lead Placement
In separate rats, bipolar cardiac pacing was conducted using
two nylon-insulated stainless steel leads ending a suture pad
as electrodes. The rat was ventilated (2.5mL/breath, 85 breaths
per min) and a right lateral thoracotomy was made in the
3rd intercostal space. The ribs were retracted and pericardium
ruptured to access and view the right atrium and adjacent
myocardium. A cotton swab was used to physically stabilize the
heart whilst one electrode pad (depolarizing lead) was sutured to
the myocardium in close proximity to the right atrium and the
other placed within the muscles of the 3rd intercostal space. The
chest was closed and negative intra-thoracic pressure reinstated
by suction. Once spontaneous breathing resumed, the electrode
leads were connected to the voltage-based stimulus output of the
PM-CPG as shown in Figure 1B.
Design of the Vagus Nerve (VN)-CPG
A comprehensive description of the design and functionality
of the VN-CPG has been published previously (Zhao and
Nogaret, 2015) and is briefly summarized here. The VN-CPG
comprises two spiking neurons 1 and 2 (N1 and N2 respectively)
interconnected through mutually inhibitory links. Each link
consists of a differential transconductance amplifier which injects
a post-synaptic current proportional to the voltage difference
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FIGURE 1 | Biological interface of the VN-CPG and PM-CPG.
Experimental setup in which the VN-CPG receives input from dEMG (A). A
view of the abdominal surface of the diaphragm shows the relative placement
of two electrodes within the costal diaphragm which are used to record dEMG
without interference from cardiac electrical activity. The black circle within the
crural diaphragm indicates the oesophageal path. The dEMG activity is
amplified and filtered by a pre-amplifier (black triangle) before use as the
respiratory input to the VN-CPG. The VN-CPG is shown (bottom right) and a
simplified representation of the differential amplifier and inhibitory interneurons,
N1 (blue) and N2 (red), that comprise the VN-CPG (detailed in Zhao and
Nogaret, 2015) and their respective firing patterns are depicted above. Either
N1 or N2 can be connected to the bipolar cuff electrode enclosing the right
cervical vagus nerve to control HR. (B) The dEMG signal was again used as a
respiratory input to the PM-CPG. The signal forming stages are indicated as
above, with the addition of a Schmitt trigger differential amplifier. The signal is
applied to N1, which generates continuous output with inspiratory modulation
of spike frequency (blue trace, inset). The output was used to pace the heart
using a myocardial bipolar electrode. dEMG, diaphragm electromyogram; N1,
neuron 1; N2, neuron 2; PM-CPG; hCPG format for use as a cardiac
pacemaker; VN-CPG, hCPG format for vagal nerve stimulation.
between the two neurons I1−→2 = g(V2−V1). Mutual inhibition
causes the two neurons to oscillate out of phase. Therefore,
when the dEMG signal is applied to N1, N1 oscillates over the
whole duration of the inspiratory phase whilst N2 remains silent
(Figure 1A, blue). N2 begins to oscillate as soon as inhibition
from N1 is released. A time delay (τ) was introduced via a RC
circuit to extend the duration of signals from N1 and slow the
rise of the current stimulating N2. This enabled fine-tuning of
N2 burst duration, such that N2 was firing during the latter
half of expiration (Figure 1A, red). Each neuron may be viewed
as an analog computer which integrates the Hodgkin-Huxley
equations in real time. The circuit models the voltage gated
conductance of the sodium, potassium, calcium, and the leakage
channels using VLSI circuits (Mahowald and Douglas, 1991;
Nogaret et al., 2013). These were implemented using discrete
current mirror components (Advanced Linear Devices) on
printed circuit boards as we described previously (Nogaret et al.,
2013). The dEMG signal consists of 50–100µV bipolar bursts.
This raw signal was pre-amplified (×104 gain) and band pass
filtered (300–500Hz; AM systems, USA) before processing by a
series of signal forming stages built on the printed hCPG circuit
board to obtain clean current pulses delimiting the inspiratory
phase. These signal forming stages included a fine amplifier (×20
gain), a rectifier stage, a controllable delay stage allowing the
duration of N1 oscillations to overlap with the expiratory phase
as desired (see below), a two stage low pass Butterworth filter,
and a transconductance amplifier converting the filtered/rectified
dEMG signal into current pulses for stimulating the hCPG.
The output stage included an impedance matching stage to
lower the output impedance of the device and allow tuning the
amplitude of neuron spikes (0–4V tuneable range). We have
performed preliminary trials of synchronization to respiration
by stimulating the hCPG with recordings of dEMG through a
NI6259 DAQ card from National Instruments.
The tuneable intra-burst stimulus parameters were intra-burst
frequency (from 1 to>500Hz) and amplitude (0–3.3V using 8V
source input). Individual spikes approximated a triangular shape
and were 2ms wide at the base. The intra-burst frequency can be
directly controlled and increased above 500Hz.
Conversion to a Direct Pacing (PM) CPG
Inducing RMHR through direct right atrial stimulation required
accurate control of the inter-spike interval. This is particularly
important during the transition between inspiratory and
expiratory periods. The accurate modulation of inter-pulse
intervals (and therefore the instantaneous HR) was achieved
using the excitatory response of neuron N1 to modulate the
frequency of sinoatrial stimulation. This approach required the
complete elimination of noise from the rectified dEMG signal
input to N1. This was achieved by additional signal forming
stages including Butterworth filters, a Schmitt trigger and a
differential amplifier (Figure 1B) to control the base HR level
and RMHR independently. The effect of smoothing dEMG by
increasing the integration time of the Butterworth filter from 10
to the 204ms used in this study is shown in Figure 2.
Experimental Protocol
Respiratory Modulation of HR Using the VN-CPG
A voltage dose-HR response curve was generated for each rat
(n = 4) by measuring the mean HR after unilateral vagotomy,
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FIGURE 2 | Low pass filtering of simulated respiratory input on the accuracy of instantaneous frequency modulation. (A) Inverse inter-spike interval of (B)
N1 stimulated by current modulation (C). This current modulation was obtained using a 10ms integration time to integrate the raw dEMG input (G). The low frequency
variations in inter-spike interval reached 1.9Hz, indicated by horizontal green lines. (D–F) same as above but using a 204ms integration time to obtain the frequency
modulation, which reduced low frequency variations in inter-spike-interval to 0.1Hz.
before and during tonic vagal nerve stimulation (20Hz) starting
at 0.5 V and increasing in 0.25V increments until the bradycardia
reached a plateau. The voltage at which a half-maximal HR
response was produced is termed V50. The 20Hz frequency
was selected as it gave the most distinct stimulus voltage-
HR response curve in pilot experiments and is within the
physiological range (McAllen et al., 2011). RMHR amplitude
was recorded during N1- and N2- based stimulation (i.e., in
phase with inspiration or expiration, respectively) at 5, 10, 20,
30, and 40Hz intra-burst frequencies. Average burst duration was
matched for N1 and N2 and each was arbitrarily set to ∼36%
of the respiratory cycle length for the above protocols while
stimulus amplitude was V50. We measured RMHR amplitude
in response to increasing burst duration (0.2 s increments from
0.2 to 0.8 s duration) of N2 only, at 20Hz intra-burst frequency
and V50.
Respiratory Modulation of HR Using the PM-CPG
To define the physiological working range of heart rates for
PM-CPG, a maximum and minimum HR was experimentally
determined in each rat (n = 4). The maximum HR was found
by metronomic pacing, starting at 450 bpm and increasing in
20 bpm increments until an ECG R wave did not produce
a blood pressure peak. This indicated ineffective ventricular
filling and/or contraction. The minimum HR was defined
as the HR 10min after atenolol (1mg/kg) was administered
intravenously. Within these pre-determined minimum and
maximum HR boundaries, rats were paced using the PM-
CPG at RMHR amplitudes of 20, 40, and 60 bpm from
the minimum HR upwards to the maximum HR in 50 bpm
increments.
Statistical Analysis
Data were analyzed using GraphPad Prism (v5). All grouped
data are mean ± SEM and a statistically significant difference
was reported when P < 0.05. Two-way ANOVA followed by
Tukey’s multiple comparison test was used to compare the effect
of VN-CPG stimulus phase (N1 and N2) and stimulus amplitude
or frequency on the amplitude of RMHR. One-way ANOVA and
Tukey’s multiple comparisons test was used to compare the effect
of RMHR generated by VN-CPG on mean HR. A one sample
t-test was used to determine if a HR waveform had significantly
phase shifted from its reference value.
RESULTS
Instantaneous Processing of Biological
Respiratory Input Signals by the VN-CPG
All experiments using the VN-CPG were conducted under
anesthesia during spontaneous breathing (67 ± 10 breaths per
min, n = 4). The gain of the VN-CPG input was finely
adjusted (up to 20×) to tune the dEMG signal of each rat
such that two distinct bursting phases were generated from
the VN-CPG outputs N1 and N2 (Figure 3A). The pattern of
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FIGURE 3 | Instantaneous VN-CPG processing enables biological feedback. (A) The amplitude and intra-burst interval of the VN-CPG N1 mimics the dEMG
input signal, where the N1 amplitude and intra-burst interval (inset) fluctuate with the height of the dEMG amplitude. N2 is inhibited when N1 activity reaches a
threshold and therefore exhibits a constant amplitude and intra-burst interval during the expiratory period. The timing of N1 bursts instantaneously adapts to
spontaneous changes in breathing (B). The duration of N1 (C) and N2 (D) are directly related to the periods of inspiration and expiration respectively. The slope of the
linear regression for N1 is 1.00 (R2 = 0.97), indicating the instantaneous processing of dEMG input and conversion into N1 stimulus output to precisely coincide with
inspiration. dEMG, diaphragm electromyogram; VN-CPG, hCPG for vagal nerve stimulation.
N1 bursts reflect precisely, and in real time, the pattern of
dEMG input signal (Figure 3A), highlighting the instantaneous
processing capabilities of the VN-CPG. That is, N1 intra-burst
interval is shortest during peak dEMG activity (Figure 3A inset).
This pattern is not observed for N2 bursting because it is not
integrating the dEMG input.
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The VN-CPG outputs responded instantly to dynamic
breathing and a representative example in Figure 3B highlights
the N1 burst duration being modulated by changes in dEMG
amplitude, frequency, and width. The accuracy of the VN-CPG
is evident from the linear relationship between N1 burst duration
and the period of inspiration (slope = 1.00, R2 = 0.97) and
between N2 burst duration and the period of expiration (slope=
0.96, R2 = 0.91) over a range of respiratory intervals (RI)
(Figures 3C,D).
The VN-CPG Controls the Phase of the
RMHR Waveform
The baseline HR waveform in anesthetized rats was associated
with respiration, where peak HR occurred during mid-late
expiration and decreased over inspiration. Different RSA patterns
have been observed in rats and this is reviewed in the discussion.
The peak-trough magnitude of this RSA was 11± 2 bpm (n = 4).
Upon connecting the VN-CPG to stimulate the vagus nerve,
spontaneous breathing became erratic (Figure 4A). Transection
of the vagus nerve cranial to the stimulating electrodes prevented
the unwanted respiratory variability caused by afferent vagal
nerve fiber activation (Figure 4B) and was routinely conducted
for subsequent experiments using the VN-CPG. RSA was 7 ±
2 bpm (n = 4) after unilateral vagotomy and the pattern, where
HR decreased during inspiration, was unchanged (Figure 5A).
The HR waveform averaged over multiple breaths (at the
same respiratory rate) approximated a sine wave, thus we could
quantify a phase shift (8) in the HR waveform generated by the
different VN-CPG stimulus modalities. The respiratory cycle was
normalized to 2pi radians and the occurrence of peak HR within
the respiratory cycle was used as a reference point for calculating
the phase shift. An example of a reference peak in HR during RSA
after unilateral vagotomy is indicated by the red line in Figure 5A
and the phase shift from this point during VN-CPG stimulation
via N1 and N2 is indicated by8 in Figures 5B,C respectively.
RMHR was induced by connecting either N1 (burst duration
26 ± 2% RI) or N2 (burst duration 31 ± 3% RI) outputs of
the VN-CPG to the right vagus nerve after unilateral nerve
transection cranial to the stimulating electrode. Connecting N1
caused a robust, transient bradycardia during late-inspiration to
mid-expiration that tended to be shifted 0.25 ± 0.08pi radians
(n = 4, P = 0.06) rightward compared to the unstimulated
HR waveform (Figure 5B). Connecting N2 generated a similarly
robust and transient bradycardia which was not significantly
shifted (0.19 ± 0.18pi radians, n = 4, P = 0.40) from the
unstimulated HRwaveform but was 0.31± 0.04pi radians (n = 4,
P = 0.003) shifted leftward from the RMHR generated by N1
(Figure 5C, N2).
N1 and N2 burst durations could be varied continuously by
tuning the decay time of slowly inactivating currents as indicated
in Figure 5D. Minimum N1 burst duration was 66 ± 2% of the
inspiratory period (TI) during slow breathing (1.0 s respiratory
interval) where TI is approximated from dEMG activity. N1
burst duration could be extended to the full respiratory interval.
Minimum N2 duration was 1 spike and could also be extended
to encompass the full respiratory interval, but from the opposite
direction to N1 (Figure 5D). An increase in N1 burst duration
from 31 ± 1 to 57 ± 4% of the respiratory interval shifted peak
HR 0.22 ± 0.05pi radians (n = 4, P = 0.02) from late expiration
to early inspiration of the following breath. A representative
example is shown in Figure 5E.
Increasing N2 burst duration from 31 ± 3 to 73 ± 6% of RI
shifted the peak HR earlier in the respiratory cycle (8 = −
0.44 ± 0.11pi radians, n = 4, P = 0.03). A representative animal
shown in Figure 5F indicates the variation on RMHR pattern
with increasing N2 burst duration.
Amplitude of RMHR Generated using the
VN-CPG
The amplitude of RMHR was controlled using the VN-CPG
via adjustment of either intra-burst frequency or stimulus
amplitude. The average voltage for half-maximal change in HR
(V50) was 1.1 ± 0.1V (n = 4). The stimulus amplitude
was changed whilst maintaining 20Hz intra-burst frequency
FIGURE 4 | Breathing stabilizes during VN-CPG stimulus after unilateral vagal nerve transection. The respiratory interval changed erratically during VN-CPG
stimulation of the vagus nerve (A). This variation was prevented by transecting the vagus nerve cranial to the stimulating electrodes, thereby blocking afferent signal
transduction (B). dEMG, diaphragmatic electromyogram; RI, respiratory interval; VN-CPG, hCPG format for vagal nerve stimulation.
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FIGURE 5 | RMHR generated by the VN-CPG: phase control. Representative examples of RSA after unilateral vagotomy (A) and during VN-CPG stimulation from
either N1 (B) or N2 (C) outputs. Shaded areas indicate the arbitrary division of the respiratory cycle into thirds: inspiration (TI), post-inspiration (PI), and late expiration
(E2). An example of the HR waveform over one respiratory cycle (2pi radians in length) is indicated on panels (A–C). The peak HR is used to align the start of the HR
waveform and this reference from panel (A) is shown as a red line. The shift of the HR waveform during N1- and N2- VN-CPG stimulation (panels B,C respectively)
from that in panel (A) is denoted by 8. The decrease in mean HR that occurred during VN-CPG stimulation from both outputs is also shown. (D) Minimum N1 burst
duration as a proportion of the respiratory interval (RI) is indicated in dark blue; its duration could be increased to the full duration of the respiratory cycle. N2 burst
duration (red), which results from the inhibitory influence of N1, could be as short as 1 spike and as long as the duration of the respiratory cycle. Panels (E,F) show
representative examples of HR waveforms from one animal where multiple N1 (blue, E) and N2 (red, F) stimulus burst durations were applied. HR waveforms were
averaged over 60 respiratory cycles, where one respiratory cycle was normalized to 2pi radians. Stimulus burst durations are expressed as a percentage of the
respiratory interval and color-coded to match the resultant HR waveforms. The duration of dEMG burst activity (TI ) is shaded gray and 8 between two waveforms is
also indicated. 2pi radians, standardized respiratory cycle period; 8, phase shift; dEMG, diaphragm electromyogram; E2, late expiration; HR, heart rate; N1, neuron 1;
N2, neuron 2; PI, post-inspiration; RMHR, respiratory-modulated heart rate; TI, period of inspiration; RI, respiratory interval; VN-CPG, hCPG for vagal nerve stimulation.
(Figures 6A,C). N1 stimulus amplitude 0.5 × V50 significantly
increased RMHR amplitude compared to the unstimulated HR
waveform (P < 0.01) and further increases up to 1.5 × V50
caused incremental, but not statistically significant, increases in
RMHR amplitude. Using N2 as the stimulus, RMHR amplitude
began to increase from baseline at 1.0× V50 (P = 0.02) and
further increased at 1.5 × V50 (P = 0.01). The maximum
RMHR amplitude (at 20Hz intra-burst frequency) was of similar
amplitude using either N1 (42 ± 6 bpm) or N2 (44 ± 10 bpm)
outputs (Figure 6A). A decrease in mean HR (44 ± 8 bpm at
1.0 × V50, n = 3) was observed during vagal nerve stimulation
using N1 and N2. Individual data points are shown in Figure 6C
as the mean change in HR was variable between rats, but not
between N1 and N2.
RMHR amplitude was also responsive to changes in
intra-burst frequency (Figure 6B) and reached a plateau at
30Hz using N1 of the VN-CPG (42 ± 5 bpm) whereas N2
of the VN-CPG produced a larger RMHR amplitude at 40Hz
intra-burst frequency (61± 5 bpm) (P < 0.05 compared to 30Hz
intra-burst frequency of N2).
Increasing N2 burst duration had a significant effect on
RMHR amplitude when the burst duration was 51–75% of RI and
RMHR amplitude decreased, on average, to unstimulated levels at
burst durations above 76% (Figure 6D). MeanHR did not change
significantly with increasing N2 burst duration. Interestingly,
doubling N1 burst duration (28 ± 2 to 56 ± 5% of RI) decreased
mean resting HR from 372± 8 to 347± 7 bpm (P = 0.04, n = 3)
but did not change the amplitude of RMHR (P = 0.07, n = 3).
Amplitude of RMHR Generated Using the
PM-CPG
The minimum HR during β-adrenergic receptor blockade was
310 ± 6 bpm and the maximum HR generated during tonic
pacing was 574 ± 20 bpm (n = 4). Within these boundaries,
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FIGURE 6 | RMHR generated by the VN-CPG: amplitude control. The magnitude of RMHR amplitude during N1- and N2-mediated vagal nerve stimulation is
linearly related to the stimulus amplitude (A) and intra-burst frequency (B). A decrease in mean HR was observed during VN-CPG stimulus at all stimulus amplitudes
(intra-burst frequency 20Hz, burst duration 36% RI for N1 and N2, n = 3) (C). N2 burst durations between 50 and 75% RI generated larger RMHR amplitudes
compared to other burst durations and RSA amplitudes after unilateral vagotomy (0% RI) (D). In panels (C,D), the response from each animal is represented by a
different symbol where filled symbols indicate a N1 response and open symbols indicate a N2 response. One-way ANOVA followed by student’s t-test where
*P < 0.05 compared to baseline, #P < 0.05 compared to lower frequency or amplitude of the same group and δP < 0.05 compared stimulus-matched N1. HR, heart
rate; RI, respiratory interval; RMHR, respiratory-modulated heart rate; V50, voltage for half maximal HR response.
rats were successfully paced using the PM-CPG at RMHR
of amplitudes 20, 40, and 60 bpm from the minimum HR
and upwards in 50 bpm incremental increases. Representative
examples from one rat are shown in Figures 7A–C where the red
trace is its minimum and maximum HR. Loss of pacing efficacy
was observed in the arterial pressure trace and indicated the
limits of RMHR pacing (representative example in Figure 7D).
The minimum mean HR during 20, 40, and 60 bpm RMHR
was 337 ± 8, 317 ± 2, and 300 ± 8 bpm respectively and the
maximum mean HR was 463 ± 21, 479± 26, and 434± 31 bpm
(Figure 7E). The HR could be effectively paced upwards from the
minimum intrinsic HR with RMHR amplitudes up to 60 bpm.
The HR during PM-CPG induced RMHR could not be paced up
to the maximum HR generated during tonic pacing.
Induction and Phase Control of
Respiratory Modulation of Heart Rate
Using the PM-CPG
Two distinct phases of RMHR could be generated by the PM-
CPG, designated “Phase 1” and “Phase 2.” In Phase 1 mode,
peak HR was synchronized to post-inspiration (PI) and trough
HR began in the latter half of expiration (E2) and continued
into inspiration (Figure 8B). In Phase 2 mode, trough HR was
synchronized predominantly to PI and peak HR began in late
expiration and continued into early inspiration (Figure 8C). The
calculated phase shift of peak HR between Phase 1 and Phase 2
modes was 1.1 ± 0.2pi radians (n = 3, P = 0.03), an inversion
of the RMHR waveform. We found that the duration of the peak
HR in Phase 1 mode could be adjusted by tuning the PM-CPG
threshold at different amplitudes of the dEMG signal: Figure 8A
is a representative dEMG burst with colored lines indicating 3
points in the continuum of possible thresholds that affect the
width of peak HR during Phase 1 RMHR shown in Figure 8B.
The duration of high HR could be tuned from the width of TI
(30% of RI, pink) up to 80% of RI (green). Changing the duration
of high HR did not shift the phase of RMHR. In Phase 2, the
dEMG threshold levels controlled the duration of trough HR to
the same extent as Phase 1 RMHR pacing (Figure 8C).
Comparison of the Control of HR and
RMHR by VN-CPG and PM-CPG during
Changes in Respiratory Rate
The effect of changing respiratory rate on the HR during VN-
CPG was tested using N1 (20Hz intra-burst frequency, burst
duration 30 ± 1% RI, n = 3). A decrease in respiratory rate
from 89 ± 2 to 59 ± 2 breaths per min during VN-CPG control
tended to increase mean HR (11± 3%, n = 3, P = 0.06). RMHR
amplitude was typically larger at faster respiratory rates (80–
86 breaths per minute). However, RMHR amplitude diminished
when the respiratory rate reached 90 breaths per minute and
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FIGURE 7 | RMHR generated by the PM-CPG: amplitude control. (A–C) Representative traces of the range of RMHR amplitudes (20, 40, and 60 bpm) and
mean HR imposed by the PM-CPG output. The minimum and maximum HR waveforms are in red. (D) A representative example of the arrhythmia occurrence that
determined the upper limit of PM-CPG pacing (red arrows). (E) Average heart rates achieved during PM-CPG pacing (n = 3) to shows the physiological upper and
lower limits of applying RMHR to rats, relative to their baseline, minimum (with β-adrenoceptor blockade), and maximum HR. dEMG, diaphragmatic electromyogram;
HR, heart rate; PM-CPG, hCPG as cardiac pacemaker; RMHR, respiratory modulated heart rate.
remained low until the respiratory rate had decreased to ∼72
breaths per minute (Figure 9A). The lack of direct control over
RMHR amplitude andmeanHR reflects a limitation to the degree
of RMHR pacing using the VN-CPG.
RMHR amplitude (76± 7 bpm) generated using the PM-CPG
was maintained during a 66 ± 3% change in respiratory rate
(80 ± 9 to 56 ± 0 breaths per minute, n = 3, P = 0.40) and a
representative example is shown in Figure 9B. Unlike VN-CPG
pacing, mean HR did not change.
DISCUSSION
The aim of this study was to test two devices built from
of a novel biofeedback hCPG platform for the application of
modulating cardiac rate by respiratory frequency with a view
to replicating intrinsic RSA. We have compared two different
pacing methods to achieve this; the VN-CPG that initiated
bradycardia via vagal nerve stimulation at different periods of
the respiratory cycle and the PM-CPG that directly paced the
heart at different rates during inspiration and expiration. The
pattern of RMHR generated by N1 of the VN-CPG and the PM-
CPG in Phase 2 were similar to each-other and most closely
matched baseline RSA in our anesthetized rats. Both the VN-CPG
and PM-CPGmaintained RMHR during spontaneous changes in
respiratory rate, highlighting the adaptive capacity of the novel
devices. However, generating RMHR using the VN-CPG always
decreased basal HR.
Differences in RMHR Generated by the
VN-CPG and PM-CPG
The pattern of RMHR induced by the VN-CPG and PM-CPG
could be adjusted to approach baseline RSA in anesthetized rats.
In these experiments, we observed that intrinsic RSA showed
a peak HR during mid-expiration and reached its nadir during
early post-inspiration at baseline. The best approximation of this
RSA was observed when using the PM-CPG in Phase 2 and
N1 of the VN-CPG to induce RMHR (where N1 burst duration
was 30–50% of the respiratory interval). The minimum HR per
breath during RMHR induced using both of these approaches
closely matched that of the intrinsic RSA generated by our
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FIGURE 8 | RMHR generated by the PM-CPG: phase control. The
duration of high HR during Phase 1 PM-CPG pacing (B) and low HR during
Phase 2 pacing (C) can be determined by adjusting the threshold at which the
PM-CPG detects dEMG signal with respect to baseline noise (A). HR
waveforms are 60 s averages with standard error indicated in gray. The color of
the waveform in each HR panel corresponds to the matching color of the
approximated threshold (dashed lines) in the top panel. The respiratory cycle is
divided into thirds as indicated by gray shading and the labels TI, PI, and E2.
dEMG, diaphragmatic electromyogram; E2, late expiration; HR, heart rate; PI,
post-inspiration; TI, period of inspiration.
anesthetized rats. However, peak HR during RMHR induced by
the VN-CPG and the PM-CPG was shifted rightward compared
to intrinsic RSA. Therefore, using N1 of the VN-CPG and the
PM-CPG in Phase 2 was the best approximation to intrinsic
RSA.
RSA is a manifestation of central respiratory gating of the
cardiac vagal pre-ganglionic nerve (McAllen and Spyer, 1978;
Gilbey et al., 1984) such that cardiac vagal nerve activity
is dampened during inspiration and elevated post-inspiration
(McAllen et al., 2011). This gating, in part, drives the respiratory
modulation of HR observed in RSA, where HR accelerates
during inspiration and decelerates during expiration (Hirsch
and Bishop, 1981; Hayano et al., 1996; Eckberg, 2003; Bouairi
et al., 2004). Inconsistencies in RSA pattern are dependent on
species [cat (Gilbey et al., 1984), dog (Anrep et al., 1936),
human (Koepchen et al., 1961; Eckberg et al., 1980)] and
anesthesia (Bouairi et al., 2004). In this study in anesthetized
rats, we consistently observed a reversal of the conventional RSA
phase at baseline. This is not unprecedented as in isofluorane-
anesthetized rats a similar pattern was observed (Tzeng et al.,
2005) and might reflect an intrinsic cardiac mechanoreceptor
response to increased intrathoracic pressure (Pathak, 1973; Taha
et al., 1995).
The variation in RSA raises the question of whether the phase
and pattern of RMHR are physiologically important. Although
our current understanding of the physiological function of
RSA is incomplete, there is some evidence to suggest phase is
important. Hayano et al., applied artificial RSA and inverse RSA
in anesthetized dogs and demonstrated that conventional RSA
increased pulmonary blood perfusion when the ratio of dead
space to total lung volume was lowest (i.e., during inspiration),
optimizing pulmonary gas exchange. The opposite was observed
during inverse RSA such that gas exchange was less efficient
compared to unmodulated HR (Hayano et al., 1996). Elstad
et al., demonstrated that RSA effectively shunts blood between
the pulmonary artery and aorta such that the increase in HR
is most effective during inspiration when venous return is
highest (Elstad, 2012). In addition, mathematical modeling of
a simplified cardiorespiratory system suggests not only that
conventional phase RSA decreases myocardial energy demand,
but inverse RSA increases myocardial energy demand compared
to unmodulated HR (Ben-Tal et al., 2012). Therefore, we
suggest that the phase of RMHR generated by our hCPG is
physiologically important.
It is well known that the amplitude of RSA fluctuates with
changes in breathing rate and is highest at lower respiratory
rates (Hirsch and Bishop, 1981). Recent mathematical modeling
of the effect of changing RSA amplitude on myocardial energy
consumption suggest that the optimal range for minimizing
energy consumption would be 10–15 bpm in humans (Ben-Tal
et al., 2014). In this paper we have demonstrated fine control over
RMHR amplitude using both the VN-CPG and PM-CPG. The
amplitude of RMHR was indirectly controlled by the VN-CPG
by manipulating its output in three ways: stimulus amplitude,
intra-burst frequency, and burst duration. Changes in stimulus
amplitude will affect RMHR amplitude up to the voltage at which
all nerve fibers are activated. The value of this voltage depends on
the nerve contact and on the VN-CPG output, which is limited to
4V.Whilst the VN-CPG is virtually unlimited in its output intra-
burst frequency, the RMHR amplitude response to N1-based
stimulus plateaued at 30Hz intra-burst frequency. This is in
accordance with the reportedmaximal firing frequency of cardiac
vagal motor neurons (McAllen et al., 2011). Increasing burst
duration above 75% of the respiratory interval decreased RMHR
amplitude suggesting the HR recovery time was insufficient
for significant HR acceleration to have an effect. Indeed, the
decreases in mean HR observed during RMHR pacing indicate
that even periodic vagal nerve stimulation reduces the efficacy
of HR acceleration to return HR to intrinsic levels. In contrast,
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FIGURE 9 | Both VN- and PM-CPG maintain RMHR during changes in respiratory frequency. Both the VN-CPG (A) and PM-CPG (B) maintain RMHR
amplitude during changes in respiratory frequency although the amplitude is more variable using VN-CPG. The VN-CPG decreases mean HR (represented as dotted
lines) whereas the PM-CPG maintains mean HR during increases in breathing rate. The heart rate trace is interpolated to fit a cubic spline instantaneous frequency of
the electrocardiogram R-wave. dEMG, diaphragmatic electromyogram; HR, heart rate; PM-CPG, hCPG as cardiac pacemaker; VN-CPG, hCPG for vagal nerve
stimulation.
RMHR amplitude could be directly controlled when using the
PM-CPG by setting the spike frequency independently during
inspiration and expiration. Therefore, the PM-CPG could be a
more attractive option for clinical translation as the heart is paced
both up and down.
A fundamental difference between using the VN-CPG and
PM-CPG is that the former is a device that slows the heart
(paces down) whereas the latter can only pace above baseline
HR. Accordingly, the RMHR waveform generated by either
neuron of the VN-CPG always decreased mean HR. This was
unavoidable and may not be appropriate in conditions where
cardiac output needs to be preserved or increased, such as heart
failure. However, physiological RSA is maximal during slow,
deep breathing when resting mean HR is relatively low (60–
80 bpm in humans) (Eckberg, 1983; De Meersman, 1992). RSA
tends to decrease in situations such as exercise where respiratory
rate and HR increase (Hatfield et al., 1998; Taylor et al., 2001).
Therefore, using the PM-CPG to generate RMHR above intrinsic
HR could be most useful at rest and may require the concurrent
use of β-adrenergic receptor blockade to lower mean HR before
generating RMHR.
VN-CPG vs. PM-CPG: A Translational
Perspective
It is well established that loss of HRV, of which RSA is a major
component, is a prognostic indicator of cardiovascular diseases
including heart failure (HF) (Algra et al., 1993; Bigger et al.,
1995; La Rovere et al., 1998). Whilst we do not fully understand
the physiological importance of RSA, recent studies utilizing
mathematical modeling suggest that RSA could conserve energy
whilst maintaining cardiac output, a feature that could be a
valuable addition to heart failure treatment. This loss of RSA in
heart failure is a direct result of decreased vagal tone (Bibevski
and Dunlap, 1999) and recent clinical trials in HF patients have
aimed to address this imbalance by direct vagal nerve stimulation
(Hauptman et al., 2012; De Ferrari et al., 2014; Premchand et al.,
2014). Whilst some of these studies have reported improvements
in cardiac function and patient health (Premchand et al., 2014;
Zannad et al., 2015) it is not clear whether the mechanism
underlying these improvements are related to increased HRV.
In this study we transected the vagus nerve to prevent afferent
nerve traffic which caused respiratory disturbances. This would
not be feasible in a clinical setting unless methods were developed
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to restrict nerve stimulation of the efferent fibers exclusively,
perhaps by incorporating anodal block stimulation. Electrode
leads and configurations have been developed in animal models
that successfully directed the propagation of vagus nerve evoked
action potentials down efferent fibers (Jones et al., 1995; Anholt
et al., 2011). Another potential drawback of the VN-CPG
approach comes from evidence suggesting that post-ganglionic
vagal nerve transmission is impaired in a canine model of heart
failure (Bibevski and Dunlap, 1999), a situation that would
prevent the use of a VN-CPG for generating RMHR if this were
the case in humans. Since the PM-CPG circumvents these issues
it may have a better outcome in clinical applications if cardiac
vagal ganglionic transmission is depressed in humans.
Current pacemakers do not recapitulate the lost HRV as
they lack sophisticated biofeedback capabilities integrating in
real time. Some attempts to rectify this have been made by
incorporating an accelerometer into the design to detect the
patient’s activity level and adjust HR accordingly (Garrigue et al.,
2002).Whilst activity-basedHR pacing improves HRV compared
to fixed-rate pacing (Raj et al., 2004), we believe that the PM-
CPG, integrating real-time respiratory activity, could provide
a significant advancement in pacing technology that would be
more efficient at controlling cardiac rate whilst simultaneously
reinstating physiologically based variability on a breath by breath
basis, something that is lost in monotonic pacing.
The hCPG electronics that underlies both the VN- and PM-
CPG was designed using analog circuits that have significant
benefits over their digital counterparts (Nogaret et al., 2015).
The unique advantage of analog electronics is that it allows
accurate real-time integration of complex physiological feedback
of neurons by the Hodgkin-Huxley model. Using a circuit design
based on artificial neurons is also advantageous because neurons
have a nonlinear response which is essential to synchronize
aperiodic biological rhythms such as respiration and heart rate.
Analog circuits present minimal overhead as analog to digital
conversion is unnecessary, minimizing power consumption, and
this presents a significant advantage in terms of miniaturization
potential and extending battery life.
CONCLUSION
We have demonstrated the utility of a novel biofeedback
device for changing heart rate with every respiratory cycle
in spontaneously breathing, anesthetized rats via the vagus
nerve (VN-CPG) and with some modification of the device,
via right atrial pacing (PM-CPG). The amplitude and phase of
respiratory modulation of HR could be finely controlled using
both approaches. However, the vagus nerve was transected and
mean HR unavoidably decreased using the VN-CPG and this
may limit its clinical application.
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